Postprandial effects on plasma lipids and satiety hormones from intake of liposomes made from fractionated oat oil: Two randomized crossover studies

Food and Nutrition Research

Volumn 58, Issue , 2014, Pages

  Ohlsson, Lena ^a   Rosenquist, Anna ^a   Rehfeld, Jens F ^b   Härröd, Magnus ^c  

^a LUND UNIVERSITY   (Sweden)

^b University of Copenhagen   (Denmark)

^c Härröd Research   (Sweden)

Author keywords

Gut health; Intestinal hormones; Liposomes; Polar lipids; Postprandial lipemia; Satiety

Indexed keywords

CHOLECYSTOKININ; FATTY ACID; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOSOME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OAT OIL; OIL; PEPTIDE YY; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; YOGHURT;

ADULT; ARTICLE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FAT INTAKE; FEMALE; FOLLOW UP; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; MEAL; NORMAL HUMAN; OAT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SATIETY; TRIACYLGLYCEROL BLOOD LEVEL; VISUAL ANALOG SCALE;

EID: 84907903596     PISSN: 16546628     EISSN: None     Source Type: Journal    
DOI: 10.3402/fnr.v58.24465     Document Type: Article

References (42)

1. Keller J, Holst JJ, Layer P. Inhibition of human pancreatic and biliary output but not intestinal motility by physiological intraileal lipid loads. Am J Physiol Gastrointest Liver Physiol 2006; 290: G704-9.
2. Layer P, Holst JJ, Grandt D, Goebell H. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci 1995; 40: 1074-82.
3. Maljaars PW, Symersky T, Kee BC, Haddeman E, Peters HP, Masclee AA. Effect of ileal fat perfusion on satiety and hormone release in healthy volunteers. Int J Obes (Lond) 2008; 32: 1633-39.
4. Chu BS, Rich GT, Ridout MJ, Faulks RM, Wickham MS, Wilde PJ. Modulating pancreatic lipase activity with galactolipids: effects of emulsion interfacial composition. Langmuir 2009; 25: 9352-60.
5. Li Y, McClements DJ. Inhibition of lipase-catalyzed hydrolysis of emulsified triglyceride oils by low-molecular weight surfactants under simulated gastrointestinal conditions. Eur J Pharm Biopharm 2011; 79: 423-31.
6. Reidelberger RD, Hernandez J, Fritzsch B, Hulce M. Abdominal vagal mediation of the satiety effects of CCK in rats. Am J Physiol Regul Integr Comp Physiol 2004; 286: R1005-12.
7. Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 1997; 273: E981-88.
8. Beglinger C, Degen L. Gastrointestinal satiety signals in humans - physiologic roles for GLP-1 and PYY? Physiol Behav 2006; 89: 460-64.
9. Van Citters GW, Lin HC. Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 2006; 8: 367-73.
10. Lovshin J, Drucker DJ. New frontiers in the biology of GLP-2. Regul Pept 2000; 90: 27-32.
11. Lund A, Vilsboll T, Bagger JI, Holst JJ, Knop FK. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes. Am J Physiol Endocrinol Metab 2011; 300: E1038-46.
12. Akesson B. Content of phospholipids in human diets studied by the duplicate-portion technique. Br J Nutr 1982; 47: 223-9.
13. Evans R, Smith IH, Jee MH, Gibson RK, Sanders NH. Viscosity reducing agent. 1988; WO88088253.
14. Jee MH. A new emulsifier from oat. Proc 21st World Congress ISF 1995;Paper 135.
15. Moreau RA, Doehlert DC, Welti R, Isaac G, Roth M, Tamura P, et al. The identification of mono-, di-, tri-, and tetragalactosyldiacylglycerols and their natural estolides in oat kernels. Lipids 2008; 43: 533-48.
16. Andersson L, Carriere F, Lowe ME, Nilsson A, Verger R. Pancreatic lipase-related protein 2 but not classical pancreatic lipase hydrolyzes galactolipids. Biochim Biophys Acta 1996; 1302: 236-40.
17. De Caro J, Sias B, Grandval P, Ferrato F, Halimi H, Carriere F, et al. Characterization of pancreatic lipase-related protein 2 isolated from human pancreatic juice. Biochim Biophys Acta 2004; 1701: 89-99.
18. Härröd M. Method for separating neutral an polar lipids and an oil rich in polar lipids. 2010; WO2010/104444.
19. Härröd M, Larsson K. Dispersions of particles of polar lipids and preparations and use thereof. 2011; WO2011/149416A1.
20. Burns AA, Livingstone MB, Welch RW, Dunne A, Reid CA, Rowland IR. The effects of yoghurt containing a novel fat emulsion on energy and macronutrient intakes in non-overweight, overweight and obese subjects. Int J Obes Relat Metab Disord 2001; 25: 1487-96.
21. Chan YK, Strik CM, Budgett SC, McGill AT, Proctor J, Poppitt SD. The emulsified lipid Fabuless (Olibra) does not decrease food intake but suppresses appetite when consumed with yoghurt but not alone or with solid foods: a food effect study. Physiol Behav 2012; 105: 742-8.
22. Undeland I, Härröd M, Lingnert H. Comparison between methods using low-toxicity solvents for the extraction of lipids from herring (Clupea harengus). Food Chem 1998; 66: 355-65.
23. Jensen RG. The composition of bovine milk lipids: January 1995 to December 2000. J Dairy Sci 2002; 85: 295-350.
24. SNF. Swedish Nutrition Recommendations. 2005; Uppsala.
25. Leonova S, Shelenga T, Hamberg M, Konarev AV, Loskutov I, Carlsson AS. Analysis of oil composition in cultivars and wild species of oat (Avena sp.). J Agric Food Chem 2008; 56: 7983-91.
26. Rehfeld JF. How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid. Regul Pept 1998; 78: 31-39.
27. Rehfeld JF, Sun G, Christensen T, Hillingso JG. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab 2001; 86: 251-58.
28. Roche HM, Gibney MJ. Postprandial triacylglycerolaemia - nutritional implications. Prog Lipid Res 1995; 34: 249-66.
29. Nakano T, Tanaka A, Okazaki M, Tokita Y, Nagamine T, Nakajima K. Particle size of apoB-48 carrying lipoproteins in remnant lipoproteins isolated from postprandial plasma. Ann Clin Biochem 2011; 48(Pt 1): 57-64.
30. Ohlsson L, Burling H, Duan RD, Nilsson A. Effects of a sphingolipid-enriched dairy formulation on postprandial lipid concentrations. Eur J Clin Nutr 2010; 64: 1344-49.
31. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002; 418: 650-54.
32. Batterham RL, Bloom SR. The gut hormone peptide YY regulates appetite. Ann N Y Acad Sci 2003; 994: 162-68.
33. Trigueros L, Pena S, Ugidos AV, Sayas-Barbera E, Perez-Alvarez JA, Sendra E. Food ingredients as anti-obesity agents: a review. Crit Rev Food Sci Nutr 2013; 53: 929-42.
34. Monsivais P, Carter BE, Christiansen M, Perrigue MM, Drewnowski A. Soluble fiber dextrin enhances the satiating power of beverages. Appetite 2011; 56: 9-14.
35. Bendtsen LQ, Lorenzen JK, Bendsen NT, Rasmussen C, Astrup A. Effect of dairy proteins on appetite, energy expenditure, body weight, and composition: a review of the evidence from controlled clinical trials. Adv Nutr 2013; 4: 418-38.
36. Montelius C, Erlandsson D, Vitija E, Stenblom EL, Egecioglu E, Erlanson-Albertsson C. Body weight loss, reduced urge for palatable food and increased release of GLP-1 through daily supplementation with green-plant membranes for three months in overweight women. Appetite 2014; 81C: 295-304.
37. Buckley JD, Howe PR. Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review. Nutrients 2010; 2: 1212-30.
38. Burns AA, Livingstone MB, Welch RW, Dunne A, Robson PJ, Lindmark L, et al. Short-term effects of yoghurt containing a novel fat emulsion on energy and macronutrient intakes in non-obese subjects. Int J Obes Relat Metab Disord 2000; 24: 1419-25.
39. Burns AA, Livingstone MB, Welch RW, Dunne A, Rowland IR. Dose-response effects of a novel fat emulsion (Olibra) on energy and macronutrient intakes up to 36 h post-consumption. Eur J Clin Nutr 2002; 56: 368-77.
40. logan CM, McCaffrey TA, Wallace JM, Robson PJ, Welch RW, Dunne A, et al. Investigation of the medium-term effects of Olibratrade mark fat emulsion on food intake in non-obese subjects. Eur J Clin Nutr 2006; 60: 1081-91.
41. Diepvens K, Steijns J, Zuurendonk P, Westerterp-Plantenga MS. Short-term effects of a novel fat emulsion on appetite and food intake. Physiol Behav 2008; 95: 114-17.
42. Smit HJ, Keenan E, Kovacs EM, Wiseman SA, Peters HP, Mela DJ, et al. No efficacy of processed Fabuless (Olibra) in suppressing appetite or food intake. Eur J Clin Nutr 2011; 65: 81-86.